nomifensine has been researched along with ADDH in 2 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buoli, M | 1 |
| Serati, M | 1 |
| Cahn, W | 1 |
| Shekim, WO | 1 |
| Masterson, A | 1 |
| Cantwell, DP | 1 |
| Hanna, GL | 1 |
| McCracken, JT | 1 |
1 review available for nomifensine and ADDH
| Article | Year |
|---|---|
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder wi | 2016 |
1 trial available for nomifensine and ADDH
| Article | Year |
|---|---|
Nomifensine maleate in adult attention deficit disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Drug Adm | 1989 |